<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: UbcH10 codes for the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related E2 Ubiquitin Conjugating Enzyme, an enzymatic molecule with a key role in the ubiquitin-proteasome pathway </plain></SENT>
<SENT sid="1" pm="."><plain>Current studies have suggested a critical role of UbcH10 in a variety of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including human thyroid, breast, ovarian and colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study has been to extend the analysis of UbcH10 expression to <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This <z:hpo ids='HP_0002664'>neoplasia</z:hpo> represents one of the leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality worldwide, and new tools for an accurate diagnosis/prognosis are needed </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The expression levels of UbcH10 were analysed in human non-small cell <z:mp ids='MP_0008714'>lung carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e>) by quantitative RT-PCR and tissue microarray immunohistochemistry, and these values were correlated with the clinicopathological features of the patients affected by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Our results demonstrate that UbcH10 is overexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e> compared to the <z:mpath ids='MPATH_458'>normal</z:mpath> lung tissue </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, UbcH10 expression is significantly higher in squamous cell and large cell <z:mp ids='MP_0002038'>carcinomas</z:mp> than in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, and directly and inversely correlated with the mutational status of p53 and EGFR, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The suppression of UbcH10 expression by RNAi resulted in a drastic reduction of proliferation and migration abilities of <z:mp ids='MP_0008714'>lung carcinoma</z:mp> cell lines </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These results, taken together, indicate that UbcH10 overexpression has a critical role in lung <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, and the evaluation of UbcH10 expression levels may be a new tool for the characterisation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e> </plain></SENT>
</text></document>